NCT02705378View on ClinicalTrials.gov

The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

December 31, 2019

Conditions
ConstipationCritical Illness
Interventions
DRUG

Polyethylene glycol

Intervention would be given by oro-gastric (OG) or naso-gastric (NG) tube

DRUG

naloxegol

Intervention would be given by OG or NG tube

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Massachusetts General Hospital

OTHER